These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3502125)
21. [Phenotype of blast cells in acute lymphoblastic leukemia]. Frenkel' MA; Baryshnikov AIu; Tupitsyn NN; Kharlamova LA Eksp Onkol; 1987; 9(3):33-6. PubMed ID: 2956082 [TBL] [Abstract][Full Text] [Related]
22. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Greaves MF; Janossy G; Peto J; Kay H Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165 [TBL] [Abstract][Full Text] [Related]
23. Leukemias and lymphomas of thymic differentiation. Borowitz MJ; Falletta JM Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085 [TBL] [Abstract][Full Text] [Related]
24. [Immunobiological features of acute lymphoblastic leukaemia]. Gavosto F Haematologica; 1983; 68(1):1-19. PubMed ID: 6404699 [No Abstract] [Full Text] [Related]
25. Markers of cellular differentiation in acute lymphoblastic leukemia. Peiper SC; Stass SA Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157 [TBL] [Abstract][Full Text] [Related]
30. Advances in the management of childhood leukemia. Bowman WP Tex Med; 1985 Mar; 81(3):39-44. PubMed ID: 3885465 [No Abstract] [Full Text] [Related]
31. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion. Han T; Gomez GA; Minowada J Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646 [TBL] [Abstract][Full Text] [Related]
32. Cell surface markers and kinetic features in acute lymphoblastic leukaemia. Caligaris Cappio F; Novarino A; Matera L; Gavosto F Haematologica; 1981 Aug; 66(4):419-25. PubMed ID: 6797877 [No Abstract] [Full Text] [Related]
33. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children]. Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083 [TBL] [Abstract][Full Text] [Related]
34. Coincident change of cellular function and phenotype in the course of a suppressor T cell acute lymphocytic leukaemia. Sieber G; Ludwig WD; Teichmann H; Herrmann F; Rühl H Clin Exp Immunol; 1985 Jun; 60(3):483-8. PubMed ID: 3160512 [TBL] [Abstract][Full Text] [Related]
35. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias]. Chen Z; Sigaux F Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390 [No Abstract] [Full Text] [Related]
36. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Greaves MF Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250 [TBL] [Abstract][Full Text] [Related]
37. Detection of relapse in acute lymphoblastic leukaemia by cusum analysis of peripheral blood-count. Morgan GJ; Thomas S; Cavill I; Bentley DP Lancet; 1987 Nov; 2(8570):1274-5. PubMed ID: 2890884 [No Abstract] [Full Text] [Related]
38. Survival and the HL-A system in acute lymphoblastic leukaemia. Lawler SD; Klouda PT; Smith PG; Till MM; Hardisty RM Br Med J; 1974 Mar; 1(5907):547-8. PubMed ID: 4522239 [TBL] [Abstract][Full Text] [Related]